Health Care • Biopharmaceuticals, GLP-1/GIP Cardiometabolic & Oncology • SIC 2834
$1,417.54 ▲ +43.84
(+3.19%)
MKT CAP: $1.34T • VOL: 5.03M
52W L $810 52W H $1,450
DISCLOSED BUY FLOW
$1.25B
DISCLOSED SELL FLOW
$807.5M
13F HEDGE FUND FILINGS
4 DISCLOSURES
CONGRESSIONAL STOCK ACT
2 FILINGS
LLY // SEC FORM 4 INSIDERS, 13F WHALES & POLITICIAN LEDGER (OWN <GO>)
WHALE DIRECTORY <13F>
| FILING DATE | FILER / INSTITUTION | CATEGORY | ACTION | SHARES | EXEC PRICE | TOTAL VALUE | DOSSIER |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Duquesne Family Office (Stanley Druckenmiller) 13F-HR Global Macro Family Office // CIK 0001536411 | HEDGE_FUND | BUY | 275.0K | $1,183.46 | $325.5M | TRACK <GO> |
| 2026-08-18 | Jonsson Patrik SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 6.5K | $1,175.10 | $7.6M | TRACK <GO> |
| 2026-08-11 | Zakrowski Donald A SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 2.0K | $1,185.01 | $2.4M | TRACK <GO> |
| 2026-08-10 | Hakim Anat SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 5.0K | $1,190.00 | $6.0M | TRACK <GO> |
| 2026-07-21 | Citadel Advisors (Ken Griffin) 13F-HR Multi-Strategy Institutional Manager // CIK 0001423053 | HEDGE_FUND | BUY | 310.0K | $1,213.91 | $376.3M | TRACK <GO> |
| 2026-07-19 | Renaissance Technologies 13F-HR Medallion Quantitative Manager // CIK 0001037389 | HEDGE_FUND | BUY | 265.0K | $1,213.91 | $321.7M | TRACK <GO> |
| 2026-06-11 | Yuffa Ilya SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 2.5K | $1,150.77 | $2.9M | TRACK <GO> |
| 2026-05-07 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 15.8K | $995.36 | $15.8M | TRACK <GO> |
| 2026-03-09 | Rep. Nancy Pelosi U.S. House Representative (CA-11) // STOCK Act PTR | POLITICIAN | BUY | 1.2K | $1,009.52 | $1.2M | TRACK <GO> |
| 2026-03-08 | Rep. Mark Green U.S. House Homeland Security Chair (TN-07) // STOCK Act PTR | POLITICIAN | BUY | 480 | $1,009.52 | $484.6K | TRACK <GO> |
| 2026-01-15 | Berkshire Hathaway (Warren Buffett) 13F-HR Value Conglomerate & Float Manager // CIK 0001067983 | HEDGE_FUND | BUY | 210.0K | $1,077.75 | $226.3M | TRACK <GO> |
| 2026-01-08 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 292.1K | $1,103.48 | $322.4M | TRACK <GO> |
| 2026-01-06 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 1.4K | $1,085.01 | $1.5M | TRACK <GO> |
| 2025-12-30 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 3.6K | $1,085.04 | $3.9M | TRACK <GO> |
| 2025-12-29 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 2.9K | $1,085.16 | $3.1M | TRACK <GO> |
| 2025-11-26 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 162.7K | $1,096.69 | $178.4M | TRACK <GO> |
| 2025-11-25 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 142.3K | $1,068.52 | $152.1M | TRACK <GO> |
| 2025-11-24 | Lilly Endowment Inc SEC Form 4 Open-Market Officer / Director | INSIDER | SELL | 105.3K | $1,058.66 | $111.5M | TRACK <GO> |